eISSN: None / ISSN: 1673-5269
Register
Login
Volume 31 Issue 6 (2024): None
Articles
Research progress on predictive markers of immunological adverse events induced by immune checkpoint inhibitors in the treatment of malignant tumors; 免疫检查点抑制剂治疗恶性肿瘤所致免疫相关不良反应预测标志物的研究进展
383-390
Influencing factors of chemotherapy related adverse drug reactions in breast cancer patients; 乳腺癌患者化疗药品不良反应影响因素研究
376-382
Application of failure mode and effects analysis in risk management of lung cancer stereotactic radiotherapy process; 失效模式和效应分析在肺癌立体定向体部放射治疗流程风险管理中的应用
369-375
Relationship between lactate dehydrogenase lactate dehydrogenase and immunotherapy effect in patients with advanced non- small cell lung cancer; 乳酸脱氢酶与晚期非小细胞肺癌患者免疫治疗效果的关系
361-390
Idebenone inhibiting growth and metastasis of hepatocellular carcinoma via regulating mitochondrial reactive oxygen species; 艾地苯醌通过调控线粒体活性氧抑制肝癌生长及转移的作用及机制
354-360
Impacts of CircFNl on radiosensitivity of esophageal squamous cell carcinoma cells by regulating miR-375/CBX3 axis; CircFNl调节miR-375/CBX3轴对食管鳞状细胞癌细胞放射敏感性的影响
345-353
Analysis of the results of colorectal cancer screening in the urban workers' medical insurance early diagnosis and early treatment project in Jinan Central Hospital from 2019 to 2023; 2019-2023年济南市中心医院城镇职工医保早诊早治项目结直肠癌筛查结果分析
340-344
Analysis of the mortality and years of life lost of esophageal cancer among residents in Pudong New Area of Shanghai from 1995 to 2022; 1995 - 2022年上海市浦东新区居民食管癌死亡特征及减寿率分析
333-339
Radiotherapy consortium chain—a blockchain-based secure cross-platform sharing solution for radiotherapy data; 放疗联盟链- 基于区块链的放疗数据跨平台安全共享方案
325-332

For any inquiries regarding the journal, publication process, or manuscript status, please contact the Editorial Office at support@cjcpt.org.

 

Authors are requested to submit their manuscripts and related documents via email at submission@cjcpt.org

 

Address: Jinan, Shandong Province, Ji Yan Road #440 - Location

 

Please contact us on WhatsApp: https://wa.me/447460013985 

Open Access Publication